Skip to main content

Recommended

Services

    PI Leaflets

      Pages

        No results found.

        Pathology tests database

        Back to Clinical Biochemistry

        Follicle Stimulating Hormone (FSH)

        Clinical Biochemistry

        Sample and container requirements

        Serum EDTA Plasma Lithium Heparin Plasma (paediatrics only)

        Minimum volume required

        Special requirements

        None

        Patient preparation

        Samples from patients receiving high biotin doses (i.e. >5 mg/day) should be taken at least 8 hours post-dose. Please inform the laboratory if the patient has been treated with monoclonal mouse antibodies or may have received them for diagnostic purposes.

        Sample viability

        Turnaround time

        This assay is run throughout the day and night. The in-lab turnaround time is normally less than 24 hours.

        Reference range

        Females: Follicular phase: 3.03 – 8.08 IU/L Luteal phase: 1.38 – 5.47 IU/L At ovulation: 2.55 – 16.69 IU/L Post – menopausal: 26.72 – 133.41 IU/L Males: 0.95 – 11.95 IU/L (Source: Abbott Diagnostics)

        Clinical guidance

        Follicle Stimulating Hormone (FSH), like Luteinising Hormone (LH), belongs to the gonadotropin family. They synergistically regulate and stimulate the growth and function of the ovaries and testes. Please refer to LabTestsOnlineUK to learn more about FSH. https://labtestsonline.org.uk/tests/fsh-test

        Notes

        Images to go here

        This information was last updated on 19 August 2026